Open App
Company / Named in our posts

Inmagene Biopharmaceuticals.

Follow Inmagene Biopharmaceuticals

Inmagene Biopharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative and differentiated therapies for immunological and inflammatory diseases.[1]

01Deal
01

Deals on Carrywatch

Every deal that names Inmagene Biopharmaceuticals, and its role in each.

Ikena Oncology, Inc. / Inmagene Biopharmaceuticals

Ikena Oncology, Inc. completed its deal for Inmagene Biopharmaceuticals.

See deal details
02

Deal Web

Inmagene Biopharmaceuticals and 1 firm it shares a posted deal with, and the path to any other firm.

03

News

Loading headlines.

04

Sources

As of 25 Oct 2026.

  1. 01
    Exhibit 99.4: Inmagene Biopharmaceuticals Condensed Consolidated Financial Statements

    U.S. Securities and Exchange Commission · Researched 25 Oct 2026

Deal posts naming Inmagene Biopharmaceuticals:

  1. P01